Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase membrane subunit g (mitochondrial), encoded by the ATP5MG gene, is a component of the F₀ sector of mitochondrial ATP synthase (Complex V). This multi-subunit enzyme complex synthesizes ATP by converting ADP and inorganic phosphate, utilizing the proton gradient generated by electron transport chain activity. The F₀ subunit forms the transmembrane proton channel, where subunit g associates as a minor peripheral component. Subunit g is unique to mitochondrial ATP synthase in animals and is not found in bacterial or chloroplast ATP synthases. Its specific structural and functional roles remain incompletely understood, but it is implicated in complex organization and proton translocation necessary for catalysis. Defects in subunit g or other complex V subunits can cause mitochondrial diseases characterized by impaired energy metabolism and multi-system dysfunction.
Inhibition of ATP synthase function via blocking proton translocation (for drugs like oligomycin and DCCD)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase membrane subunit g, mitochondrial (ATP5MG).